Exclusive: Response Pharmaceuticals raises millions to combat weight gain from antipsychotic drugs


The company plans to test an experimental drug in weight gain associated with common treatments for mental illnesses.

Previous Heal plans layoffs amid sale discussions
Next Nashville's health care industry has a rough 2022 on the stock market